| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $143.15B | -2.9% |
| Cost of Revenue | $129.96B | +1.5% |
| R&D Expense | $15.0M | -44.4% |
| SG&A Expense | $2.81B | +11.4% |
| Interest Expense | $907.0M | +1.1% |
| Income Tax | $500.0M | -77.6% |
| Net Income | $2.12B | -69.8% |
| EPS (Basic) | $5.01 | -67.8% |
| EPS (Diluted) | $4.99 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.74B | -47.7% |
| Accounts Receivable | $11.03B | -5.9% |
| Inventory | $4.00B | +6.5% |
| Current Assets | $17.91B | -10.2% |
| Total Assets | $72.58B | -3.9% |
| Current Liabilities | $15.09B | -4.8% |
| Long-term Debt | $18.23B | +2.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.19B | -40.4% |
| Investing Cash Flow | -$2.46B | -37.6% |
| Financing Cash Flow | -$3.31B | +59.2% |
| -67.8% |
| Total Liabilities |
| $44.12B |
| +0.6% |
| Stockholders' Equity | $27.41B | -10.4% |